Fluicell CEO Newsletter 05, 2022
2022 has been a busy year for us at Fluicell. Not only have we this year released Biopixlar…
Fluicell is transforming healthcare through innovative bioprinting and microfluidic research solutions, and tissue-based regenerative medicine, starting from the perspective of the individual cell.
2022 has been a busy year for us at Fluicell. Not only have we this year released Biopixlar…
Today, November 30 2022, Fluicell publishes the interim report for the period July 1 to September 30, 2022….
Biopixlar AER is nominated as Innovation of the Year for the 2022 3D Printing Industry Awards! We at…